SCHEMBL23928896

SCHEMBL23928896

O=C1CC2(CN(C(=O)O)C2)Oc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.53
EPHX2 P34913 4/20 0.52
CYP2C9 P11712 1/20 0.52
CHRNA7 P36544 4/20 0.50
ATM Q13315 1/20 0.49
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
EPHX1 P07099 2/20 0.48
SCN5A Q14524 1/20 0.48
HRH3 Q9Y5N1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3213563 0.90 SIGMAR1 (0.60) SIGMAR1EPHX2CYP2C9HDAC3HDAC4
SCHEMBL3213557 0.90 SIGMAR1 (0.60) SIGMAR1EPHX2CYP2C9HDAC3HDAC4
SCHEMBL3222598 0.87 SIGMAR1 (0.66) SIGMAR1EPHX2CYP2C9ATMHDAC3
SCHEMBL2588053 0.87 SIGMAR1 (0.66) SIGMAR1EPHX2CYP2C9ATMHDAC3
SCHEMBL23928878 0.81 CHRNA7 (0.54) CHRNA7HDAC3HDAC4HDAC1HDAC7
SCHEMBL23928885 0.81 ACACB (0.49) CHRNA7ATMHDAC3HDAC4HDAC1
SCHEMBL16291672 0.81 HDAC3 (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL23928877 0.80 ATM (0.51) SIGMAR1EPHX2CHRNA7ATMHDAC3
Hydrochloric Acid SCHEMBL21617950 0.79 SIGMAR1 (0.52) SIGMAR1EPHX2CYP2C9CHRNA7ATM
SCHEMBL23928898 0.78 EPHX2 (0.54) EPHX2HDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820869-B1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT (HU) 2023-08-30 EP disclosed
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330650-A1 SPIROCHROMANE DERIVATIVES CHRNA7, CHRM3, ADRB3 SIGMAR1 355/4885EPHX2 1079/4885CYP2C9 499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.